无乳链球菌致病因子的研究进展

›› 2013, Vol. 40 ›› Issue (10): 220-223.

无乳链球菌致病因子的研究进展

夏杰¹, 易弋¹, 罗福广², 杨军^2,3, 王佳¹, 伍时华¹, 黄稀³

1. 广西工学院生物与化学工程系, 广西柳州 545006;
2. 柳州市渔业技术推广站, 广西柳州 545006;
3. 柳州市鱼家乐饲料有限公司, 国家罗非鱼产业技术体系柳州综合试验站, 广西柳州 545002

收稿日期:2013-03-12 出版日期:2013-10-20 发布日期:2013-12-19
通讯作者: 易弋 E-mail:airhfh@163.com
作者简介:夏杰(1988-),男,浙江人,硕士生,研究方向:微生物分子。
基金资助:
国家现代农业产业技术体系专项资金项目(CARS-49);广西科技重大专项项目(桂科攻1123006-3)。

Research Progress on Pathogenic Factors in Streptococcus agalactiae

XIA Jie¹, YI Yi¹, LUO Fu-guang², YANG Jun^2,3, WANG Jia¹, WU Shi-hua¹, HUANG Xi³

1. College of Biological and Chemical Engineering, Guangxi University of Technology, Liuzhou 545006, China;
2. Liuzhou Fishery Technical Extension Station, Liuzhou 545006, China;
3. Liuzhou Yujiale Feed Co., Ltd., Liuzhou Comprehensive Experiment Station of the National Tilapia Industry Technology System, Liuzhou 545002, China

Received:2013-03-12 Online:2013-10-20 Published:2013-12-19

摘要/Abstract

摘要： 无乳链球菌是人和动物的主要致病菌之一,该菌可引起人和动物的脑膜炎、肺炎、败血症等疾病。目前已发现的无乳链球菌主要致病因子包括荚膜多糖、溶血素、透明质酸酶、环磷酸腺苷(CAMP)因子、超氧化物歧化酶和丝氨酸/苏氨酸蛋白激酶等。作者就上述几类致病因子进行综述,介绍了近年来国内外无乳链球菌的致病性及致病机理等方面的一些研究进展。

关键词: 无乳链球菌; 致病因子; 致病机理; 进展

Abstract: One of the main pathogens of humans and animals was Streptococcus agalactiae, which could cause disease such as meningitis, pneumonia and septicemia. At the moment, the major pathogenic factors of Streptococcus agalactiae had been found including capsular polysaccharide, hemolysin, hyaluronidase, CAMP factor, superoxide dismutase, serine-threonine protein kinase and so on. A few kinds of pathogenic factors above were reviewed, in which some of the research progress about the pathogenic and pathogenesis of Streptococcus agalactiae at home and abroad in recent years were also introduced.

Key words: Streptococcus agalactiae; pathogenic factor; pathogenesis; progress

中图分类号:

S855.9⁺9

夏杰, 易弋, 罗福广, 杨军, 王佳, 伍时华, 黄稀. 无乳链球菌致病因子的研究进展[J]. , 2013, 40(10): 220-223.

XIA Jie, YI Yi, LUO Fu-guang, YANG Jun, WANG Jia, WU Shi-hua, HUANG Xi. Research Progress on Pathogenic Factors in Streptococcus agalactiae[J]. , 2013, 40(10): 220-223.

参考文献

1 Dal M C,Monteil H. Hemolysin produced by group B Streptococcus agalactiae[J]. FEMS Microbiology Letters,1983,16(1): 89~94.
2 Doran K S,Liu G Y,Nizet V. Group B streptococcal β-hemolysin/cytolysin activates neutrophil signaling pathways in brain endothelium and contributes to development of meningitis[J]. The Journal of Clinical Investigation,2003,112(5): 736~744.
3 Eldar A,Bejerano Y,Livoff A,et al. Experimental streptococcal meningo-encephalitis in cultured fish[J]. Veterinary Microbiology,1995,43(1): 33~40.
4 Finch L A,Martin D R. Human and bovine group B Streptococci: Two distinct populations[J]. Journal of Applied Microbiology,1984,57(2): 273~278.
5 Hassan A A,Abdulmawjood A,Yildirim A O,et al. Identification of streptococci isolated from various sources by determination of cfb gene and other CAMP-factor genes[J]. Canadian Journal of Microbiology,2000,46(10): 946~951.
6 Jiang S M,Cieslewicz M J,Kasper D L,et al. Regulation of virulence by a two-component system in group B Streptococcus[J]. Journal of Bacteriology,2005,187(3): 1105~1113.
7 Jiang S M,Ishmael N,Hotopp J D,et al. Variation in the group B Streptococcus CsrRS regulon and effects on pathogenicity[J].Journal of Bacteriology,2008,190(6): 1956~1965.
8 Keefe G P. Streptococcus agalactiae mastitis: A review[J]. Canadian Veterinary Journal,1997,38: 429~437.
9 Lamy M C,Zouine M,Fert J,et al. CovS/CovR of group B Streptococcus: A two-component global regulatory system involved in virulence[J]. Molecular Microbiology,2004,54(5): 1250~1268.
10 Lang S,Palmer M. Characterization of Streptococcus agalactiae CAMP factor as a pore-forming toxin[J]. Journal of Biological Chemistry,2003,278(40): 38167~38173.
11 Lembo A,Gurney M A,Burnside K,et al. Regulation of CovR expression in group B Streptococcus impacts blood-brain barrier penetration[J]. Molecular Microbiology,2010,77(2): 431~443.
12 Lin B,Hollingshead S K,Coligan J E,et al. Cloning and expression of the gene for group B streptococcal hyaluronate lyase[J]. Journal Biological Chemistry,1994,269: 30113~30116.
13 Liu G Y,Doran K S,Lawrence T,et al. Sword and shield: Linked group B streptococcal beta-hemolysin/cytolysin and caro-tenoid pigment function to subvert host phagocyte defense[J]. Proceeding Natural Academy Science USA,2004,101(40): 14491~14496.
14 Lokeshwar V B,Soloway M S,Block N L. Secretion of bladder tumor-derived hyaluronidase activity by invasive bladder tumor cells[J].Cancer Letters,1998,131(1): 21~27.
15 Madoff L C,Paoletti L C,Tai J Y,et al. Maternal immunization of mice with group B streptococcal type Ⅲ polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes[J]. The Journal of Clinical Investigation,1994,94(1): 286~292.
16 Ozegowski J H,Gunther E,Reichardt W. Purification and characterization of hyaluronidase from Streptococcus agalactiae[J]. Zentralblatt für Bakteriologie,1994,280(4): 497~506.
17 Poyart C,Quesne G,Coulon S,et al. Identification of streptococci to species level by sequencing the gene encoding the manganese-dependent superoxide dismutase[J]. Journal Clinical Microbiology,1998,36(1): 41~47.
18 Poyart C,Pellegrini E,Gaillot O,et al. Contribution of Mn-Cofactored superoxide dismutase (SodA) to the virulence of Streptococcus agalactiae[J]. Infection and Immunity,2001,69(8): 5098~5106.
19 Pritchard D G,Lin B,Willingham T R,et al. Characterization of the group B streptococcal hyaluronate lyase[J]. Archives of Biochemisty and Biophysics,1994,315(2): 431~437.
20 Rajagopal L,Clancy A,Rubens C E. A eukaryotic type serine/threonine kinase and phosphatase in Streptococcus agalactiae reversibly phosphorylate an inorganic pyrophosphatase and affect growth,cell segregation,and virulence[J]. The Journal of Biological Chemistry,2003,278(16): 14429~14441.
21 Rajagopal L,Vo A,Silvestroni A,et al. Regulation of cytotoxin expression by converging eukaryotic-type and two-component signalling mechanisms in Streptococcus agalactiae[J]. Molecular Microbiology,2006,62(4): 941~957.
22 Ring A,Braun J S,Pohl J,et al. Group B streptococcal β hemolysin induces mortality and liver injury in experimental sepsis[J]. The Journal of Infectious Diseases,2002,185(12): 1745~1753.
23 Rubens C E,Wessels M R,Heggen L M,et al. Transposon mutagenesis of group B streptococcal type Ⅲ capsular polysaccharide: Correlation of capsule expression with virulence[J]. Proceedings of the National Academy Science USA,1987,84(20):7208~7212.
24 Salasia S I,Wibawan I W,Lammler C,et al. Phase variation in Streptococci of serological group B[J]. APMIS,1994,102(7~12): 925~930.
25 Segura M A,Clßroux P,Gottschalk M. Streptococcus suis and group B Streptococcus differ in their interactions with murine macrophages[J]. FEMS Immunology&Medical Microbiology,1998,21(3):189~195.
26 Shalka B,Smola J. Lethal effect of CAMP-factor and UBERIS-factor: A new finding about diffusible exosubstances of Streptococcus agalactiae and Streptococcus uberis[J]. Zentralblatt für Bakteriologie,1981,249(2): 190~194.
27 Spellerberg B,Pohl B,Haase G,et al. Identification of genetic determinants for the hemolytic activity of Streptococcus agalactiae by ISS1 transposition[J]. Journal Bacteriology,1999,181(10): 3212~3219.
28 Spellerberg B. Pathogenesis of neonatal Streptococcus agalactiae infections[J]. Microbes and Infection,2000a,2(14): 1733~1742.
29 Spellerberg B,Martin S,Brandt C,et al. The cyl genes of Streptococcus agalactiae are involved in the production of pigment[J]. FEMS Microbiology Letters,2000b,188(2): 125~128.
30 Weat A H,Stock A M. Histidine kinases and response regulator proteins in two-component signaling system[J]. Trends in Biochemical Sciences,2001,26(6): 369~376.
31 Wessels M R,Benedi W J,Jennings H J,et al. Isolation and characterization of type Ⅳ group B Streptococcus capsular polysaccharide[J]. Infection and Immunity,1989a,57(4): 1089~1094.
32 Wessels M R,Rubens C E,Benedi V J,et al. Definition of a bacterial virulence factor: Sialylation of the group B streptococcal capsule[J]. Proceedings of the National Academy Science USA,1989b,86(22): 8983~8987.
33 Yildirim A O,Lammler C,Weiss R. Identification and characterization of Streptococcus agalactiae isolated from horses[J]. Veterinary Microbiology,2002a,85(1): 31~35.
34 Yildirim A O,Lammler C,Weiss R,et al. Pheno-and genotypic properties of streptococci of Serological group B of canine and feline origin[J]. FEMS Microbiology Letters,2002b,212(2): 187~192.

[1]	施金谷, 黄珊珊, 黄基伟, 陈坤海, 胡大胜, 朱志雄, 韩书煜. 高温胁迫下罗非鱼源无乳链球菌的比较转录组分析[J]. 中国畜牧兽医, 2023, 50(6): 2207-2216.
[2]	宋越, 苏胜杰, 张帆, 白帆, 戴伶俐, 王娜, 王大伟, 杨茜雯, 赵世华, 张月梅. 溶血性曼氏杆菌截短型白细胞毒素的原核表达及多克隆抗体制备[J]. 中国畜牧兽医, 2023, 50(6): 2479-2486.
[3]	袁橙, 陈怀君, 袁圣, 温华茂, 陈智怡, 董洪燕, 封琦, 郭长明. 福建省漳州市罗非鱼无乳链球菌分离鉴定及毒力基因和耐药性研究[J]. 中国畜牧兽医, 2022, 49(9): 3655-3664.
[4]	张振宇, 王勇. 乳与乳制品中黄曲霉毒素检测研究进展[J]. 中国畜牧兽医, 2022, 49(7): 2820-2830.
[5]	胡湘云, 潘鹏丞, 吴倍仪, 陈宝剑, 覃兆鲜, 谢炳坤. 猪德尔塔冠状病毒致病机理及防治研究进展[J]. 中国畜牧兽医, 2022, 49(10): 3994-4003.
[6]	陈怀君, 郭长明, 朱善元, 吴植, 袁圣, 王永娟, 袁橙, 潘勇, 王晓晔. 海南罗非鱼源无乳链球菌的分离鉴定及生物学特性研究[J]. 中国畜牧兽医, 2021, 48(8): 3058-3068.
[7]	郭长明, 陈怀君, 袁橙, 罗福广, 黄德生, 贾国华, 袁圣, 朱善元. 广西罗非鱼无乳链球菌的分离鉴定、毒力基因及耐药性研究[J]. 中国畜牧兽医, 2021, 48(7): 2607-2616.
[8]	杨涛, 崔冉, 张新浩, 杨莉, 王敏, 刘宇, 凌遥, 李海静, 赵春江. 东阿黑驴育种规划优化的研究[J]. 中国畜牧兽医, 2021, 48(10): 3670-3681.
[9]	孙佳丽, 董浩, 彭小薇, 朱良全, 蒋卉, 冯宇, 李筱英, 丁家波, 王春凤. 犬种布鲁氏菌研究进展[J]. 中国畜牧兽医, 2021, 48(10): 3803-3811.
[10]	范雪, 邵伟, 赵艳坤, 杜晓慧, 陈贺, 王富兰. 无乳链球菌毒力基因与耐药性的相关性研究进展[J]. 中国畜牧兽医, 2021, 48(1): 375-384.
[11]	单玉雪, 杨娜, 滕达, 王秀敏, 毛若雨, 郝娅, 马炫炫, 范寰, 王建华. 抗菌肽NZ2114对来源于奶牛乳房炎的无乳链球菌及其生物膜的消杀作用[J]. 中国畜牧兽医, 2020, 47(7): 2284-2294.
[12]	郭长明, 吴植, 吴双, 王永娟, 王安平, 刘广锦, 刘永杰, 朱善元. 无乳链球菌dnaJ基因缺失株的构建及其致病性研究[J]. 中国畜牧兽医, 2019, 46(9): 2507-2515.
[13]	韩斐, 江明锋, 王刚. 胰高血糖素样肽-2及其在畜牧生产中的应用[J]. 《中国畜牧兽医》, 2019, 46(6): 1612-1618.
[14]	林厦菁, 苟钟勇, 蒋守群. 2017-2018年黄羽肉鸡饲料营养研究进展[J]. 《中国畜牧兽医》, 2019, 46(4): 1018-1030.
[15]	孙宏宇, 索朗斯珠, 徐业芬, 牛家强, 姚一龙, 张入丹, 王冬经. 牛主要抗病候选基因的研究进展[J]. 《中国畜牧兽医》, 2018, 45(7): 1912-1918.